Skip to main content
OpenTrials

Clinical trial condition

KRAS G12V

Explore clinical trials studying KRAS G12V. Study availability and eligibility vary by location and protocol.

7 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

KRAS G12V trial results

Recruiting

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

NCT05786924

Conditions
Acquired Resistance to KRAS G12C Inhibitor, BRAF, BRAF Gene Mutation, +61 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • The Angeles clinic - A cedars SINAI AFFILIATE Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
View all 27 locations
View Trial Details
Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

NCT06917079

Conditions
Advanced Lung Carcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +34 more
Locations
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • University of California Davis Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

NCT05726864

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +24 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

NCT06105021

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • USC Norris Comprehensive Los Angeles, California, United States
  • University of California Los Angeles Department of Medicine Los Angeles, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
View Trial Details

Related conditions